Powder: -20°C for 3 years | In solvent: -80°C for 1 year
UbcH5c-IN-1 is a selective small-molecule Ubiquitin-conjugating enzyme UbcH5c inhibitor (Kd: 283 nM for E2 UbcH5c-IN-1 by covalent binding with Cys85).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | UbcH5c-IN-1 is a selective small-molecule Ubiquitin-conjugating enzyme UbcH5c inhibitor (Kd: 283 nM for E2 UbcH5c-IN-1 by covalent binding with Cys85). |
Targets&IC50 | E2 UbcH5c:(kd)283 nM |
In vivo | In Freund's adjuvant (CFA)-induced adjuvant arthritis (AA) rat model, UbcH5c-IN-1 (5 and 20 mg/kg, p.o., daily, 10-20 days) treatment results in appreciable decreases in the arthritis index score and hind paw swelling rate compared with those of the vehicle-treated AA model control group. |
Molecular Weight | 413.3 |
Formula | C22H21BrO3 |
CAS No. | 2123480-72-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
UbcH5c-IN-1 2123480-72-6 Others UbcH5c IN 1 UbcH5cIN1 UbcH-5c-IN-1 inhibitor inhibit